Correction: The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth

Jing Qian^{1

2}, Yanxia Ma^{1

3}, William M Tahaney^{1

4

5}, Cassandra L Moyer¹, Amanda Lanier¹, Jamal Hill¹, Darian Coleman¹, Negar Koupaei^{1

6}, Susan G Hilsenbeck⁷, Michelle I Savage¹, Brent D G Page⁸, Abhijit Mazumdar¹, Powel H Brown^{9

10}

Affiliations

¹ Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
² The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, USA.
³ Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁴ Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
⁵ Monte Rosa Therapeutics, Boston, USA.
⁶ Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁷ Lester and Sue Smith Breast Center and Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
⁸ Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
⁹ Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. PHBrown@mdanderson.org.
¹⁰ Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA. PHBrown@mdanderson.org.

Published Erratum

Jing Qian et al. Breast Cancer Res. 2024.

. 2024 Mar 26;26(1):53.

doi: 10.1186/s13058-024-01814-9.

¹ Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
² The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, USA.
³ Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁴ Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
⁵ Monte Rosa Therapeutics, Boston, USA.
⁶ Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁷ Lester and Sue Smith Breast Center and Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
⁸ Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
⁹ Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. PHBrown@mdanderson.org.
¹⁰ Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA. PHBrown@mdanderson.org.

No abstract available

Erratum for

The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth.
Qian J, Ma Y, Tahaney WM, Moyer CL, Lanier A, Hill J, Coleman D, Koupaei N, Hilsenbeck SG, Savage MI, Page BDG, Mazumdar A, Brown PH. Qian J, et al. Breast Cancer Res. 2024 Feb 5;26(1):23. doi: 10.1186/s13058-024-01778-w. Breast Cancer Res. 2024. PMID: 38317231 Free PMC article.

1. Qian J, Ma Y, Tahaney WM, et al. The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth. Breast Cancer Res. 2024;26:23. doi: 10.1186/s13058-024-01778-w. - DOI - PMC - PubMed